For a Commentary on this article, please see Nakamura (J Bone Miner Res. 2014;29:287–289. DOI: 10.1002/jbmr.2161).
MHC Class II Transactivator Is an In Vivo Regulator of Osteoclast Differentiation and Bone Homeostasis Co-opted From Adaptive Immunity
Version of Record online: 17 JAN 2014
© 2014 American Society for Bone and Mineral Research
Journal of Bone and Mineral Research
Volume 29, Issue 2, pages 290–303, February 2014
How to Cite
Benasciutti, E., Mariani, E., Oliva, L., Scolari, M., Perilli, E., Barras, E., Milan, E., Orfanelli, U., Fazzalari, N. L., Campana, L., Capobianco, A., Otten, L., Particelli, F., Acha-Orbea, H., Baruffaldi, F., Faccio, R., Sitia, R., Reith, W. and Cenci, S. (2014), MHC Class II Transactivator Is an In Vivo Regulator of Osteoclast Differentiation and Bone Homeostasis Co-opted From Adaptive Immunity. J Bone Miner Res, 29: 290–303. doi: 10.1002/jbmr.2090
- Issue online: 17 JAN 2014
- Version of Record online: 17 JAN 2014
- Accepted manuscript online: 3 SEP 2013 07:27AM EST
- Manuscript Accepted: 22 AUG 2013
- Manuscript Revised: 30 JUL 2013
- Manuscript Received: 28 FEB 2013
- Swiss National Science Foundation, the National Center of Competence in Research on Neural Plasticity and Repair (NCCR-NEURO)
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.